To identify immune variables associated with SARS-CoV-2 infection that may persist following COVID-19 resolution, we evaluated in detail the immune profile of a cohort of CP donors assessed at median 60 days after either the onset of symptoms or a positive PCR result. The gene discussed is CP; the disease is COVID-19.